Web5 apr 2024 · 胃がんグループJCOG1001最終解析の結果がBritish Journal of Surgeryに掲載されました 消化器内視鏡グループJCOG0607S3の結果がDigestive Endoscopy に掲載されました JCOG学会発表情報 （JCOG研究に関する発表が予定されている学会です） 第40回 日本脳腫瘍学会学術集会 2024/12/4-6 JCOG0911A2（脳腫瘍グループ／木下 学 先生 旭 … Web11 Background: Six months of oxaliplatin-based adjuvant chemotherapy in patients with stage III colon cancer (CC) remains a standard in high-risk stage III patients. Early treatment discontinuation (ETD) could worsen the prognosis. In addition, there is current lack of data on the prognostic impact of early oxaliplatin only discontinuation (EOD). Methods: We …
JCOG1008
Web25 gen 2024 · III期JCOG1018研究 (RESPECT)：在老年转移性结直肠癌患者中，mFOLFOX7或CapeOX联合贝伐珠单抗 vs 5-FU/l-LV或卡培他滨联合贝伐珠单抗的初始治疗疗效 A randomized phase III trial of mFOLFOX7 or CapeOX plus bevacizumab versus 5-FU/l-LV or capecitabine plus bevacizumab as initial therapy in elderly patients with … Web4 apr 2024 · 主要評価項目及び副次評価項目のデータ解析及び結果: 公開予定日: 要約: 研究実施計画書のurl: 結果に関する最初の出版物での発表日: 結果と出版物に関するurl malad hypercity
Yukihide Kanemitsu, MD on Twitter: "RT @JCOG_official: #GI22 …
Web20 gen 2024 · A survey study of prevention and treatment patterns by academic and community oncologists for cancer therapy-associated diarrhea. Incidence, severity, and onset of oral mucositis in 5-FU based chemotherapy for gastrointestinal cancer. Adjuvant oxaliplatin and fall-related injury in patients with colorectal cancer. Web26 set 2012 · JCOG1018: Rp3 Study in Elderly Patients with MEtastatic CRC as 1st-line Tx. Basic Information. Recruitment status: Complete: Health condition(s) or Problem(s) studied: Metastatic clorectal cancer: Date of first enrollment: 26/09/2012: Target sample size: 250: Countries of recruitment: Study type: Web1 feb 2024 · Two phase III clinical trials conducted in elderly mCRC patients compared FP to combination therapy with oxaliplatin (FOCUS 2 trial [15]) and irinotecan (FFCD 2001-02 [16]), respectively, neither ... malad idaho hotels and motels